Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes:...

por Komajda, Michel, Curtis, Paula, Hanefeld, Markolf, Beck-Nielsen, Henning, Pocock, Stuart J, Zambanini, Andrew, Jones, Nigel P, Gomis, Ramon, Home, Philip D
Publicado 2008

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial

por Komajda, Michel, McMurray, John J.V., Beck-Nielsen, Henning, Gomis, Ramon, Hanefeld, Markolf, Pocock, Stuart J., Curtis, Paula S., Jones, Nigel P., Home, Philip D.
Publicado 2010

Incidence and Prevalence of Unrecognized Myocardial Infarction in People With Diabetes: A substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in...

por MacDonald, Michael R., Petrie, Mark C., Home, Philip D., Komajda, Michel, Jones, Nigel P., Beck-Nielsen, Henning, Gomis, Ramon, Hanefeld, Markolf, Pocock, Stuart J., Curtis, Paula S., McMurray, John J.V.
Publicado 2011